| Gene symbol | TRBC1 | Synonyms | BV05S1J2.2, TCRB, TCRBC1 | Type of gene | other |
| Chromosome | 7 | Map location | 7q34 | dbXrefs | |
| Description | T cell receptor beta constant 1 | ||||
| GTO ID | GTC0445 |
| Trial ID | NCT03590574 |
| Disease | Angioimmunoblastic T-Cell Lymphoma | Anaplastic Large Cell Lymphoma | T-Cell Non-Hodgkin's Lymphoma | Peripheral T-Cell Lymphoma |
| Altered gene | TRBC1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | AUTO4 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Phase I/II Study Evaluating AUTO4 in Patients With TRBC1 Positive T Cell Lymphoma |
| Year | 2018 |
| Country | United States |
| Company sponsor | Autolus Limited |
| Other ID(s) | AUTO4-TL1|2017-001965-26 |
| Cohort 1 | |||||||||||||||||
|
|||||||||||||||||